Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02043496
Other study ID # PSYCH-2016-22310
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 2013
Est. completion date August 2017

Study information

Verified date July 2020
Source University of Minnesota
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to test a newly developed individual psychotherapy treatment for binge eating disorder in adults. This treatment is a type of individual psychotherapy called Integrative Cognitive-Affective Therapy (ICAT) that focuses on helping people change their behaviors, feelings, thoughts about themselves, and relationships. This new treatment is being compared to an existing treatment called Cognitive-Behavior Therapy-Guided Self Help (CBTgsh), which focuses on changing behavior patterns through the use of reading and homework assignments along with sessions with a therapist. The primary hypothesis of this investigation is that ICAT will be associated with greater reductions in binge eating at end of treatment and follow-up compared to CBTgsh.


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date August 2017
Est. primary completion date August 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Binge eating disorder (DSM-5)

Exclusion Criteria:

- History of gastric bypass surgery

- Medical condition acutely affecting eating and/or weight

- Current medical and/or psychiatric instability (e.g., acute suicidality)

- Psychosis and/or bipolar disorder

- Severe cognitive impairment or developmental disability

- Inability to read English

- Current substance use disorder

- Current participation in psychotherapy and/or commercial weight loss program

- Change in dosage and/or frequency of psychotropic medication in the past 6 weeks

- Pregnant or breast feeding

- BMI < 21

Study Design


Intervention

Behavioral:
Integrative Cognitive-Affective Therapy
Integrative Cognitive-Affective Therapy is a psychotherapy treatment for binge eating that focuses on changing behaviors, feelings, thoughts, and relationships
CBT-Guided Self Help
CBT-Guided Self Help focuses on changing behavior patterns through the use of reading and homework assignments along with sessions with a therapist.

Locations

Country Name City State
United States Neuropsychiatric Research Institute Fargo North Dakota
United States University of Minnesota Minneapolis Minnesota

Sponsors (2)

Lead Sponsor Collaborator
University of Minnesota Neuropsychiatric Research Institute, Fargo, North Dakota

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Binge Eating Episode Frequency (Eating Disorder Examination) Frequency of binge eating as measured by the Eating Disorder Examination 17 Weeks and 6-month Follow-up
Secondary Global Eating Disorder Symptoms (EDE) Global Eating Disorder Symptoms as measured by the Eating Disorder Examination 17 Weeks and 6-month follow-up
Secondary Symptoms of Depression (BDI) Symptoms of Depression as measured by the Beck Depression Inventory 17 Weeks and 6-month follow-up
Secondary Symptoms of Anxiety (STAI) Symptoms of Anxiety as measured by the State-Trait Anxiety Inventory 17 Weeks and 6-month Follow-up
Secondary Self-Esteem (RSEQ) Self-esteem as measured by the Rosenberg Self-Esteem Questionnaire 17 Weeks and 6-month Follow-up
See also
  Status Clinical Trial Phase
Withdrawn NCT02978742 - Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder N/A
Recruiting NCT02659488 - Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects Phase 2
Completed NCT02659475 - Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED) Phase 2
Completed NCT00601653 - Effectiveness of Cognitive Behavioral Therapy Plus Nutritional Counseling in Promoting Weight Loss in People With Binge Eating Disorder N/A
Completed NCT02834299 - Dialectical Behavior Therapy Guided Self-Help for Binge Eating Disorder N/A
Completed NCT02553824 - FDA Approved Medication to Reduce Binge Eating and/or Purging Phase 1
Completed NCT02564588 - Dasotraline Binge Eating Disorder Study Phase 2/Phase 3
Completed NCT00307190 - Hormone Release and Stomach Disturbances in People With Binge Eating Disorder N/A
Completed NCT01718483 - SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder Phase 3
Completed NCT01718509 - SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder Phase 3
Completed NCT02503098 - Optimizing a Smartphone Application for Individuals With Eating Disorders N/A
Active, not recruiting NCT01837953 - Stepped Care for Binge Eating Disorder: Predicting Response to Minimal Intervention in a Randomized Controlled Trial N/A
Completed NCT01010789 - Armodafinil in Binge Eating Disorder (BED) Phase 3
Completed NCT01098435 - ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder Phase 2
Completed NCT01552759 - Appetite Hormones in Binge Eating Disorder N/A
Completed NCT00330655 - An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder Phase 4
Completed NCT01291173 - Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder Phase 2
Completed NCT03107026 - A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder Phase 3
Completed NCT02079935 - Treatment of Eating Disorders by Physical Activity and Nutrition Counseling N/A
Completed NCT00277641 - Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity Phase 3